PMC:7796072 / 16466-17571 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"589","span":{"begin":9,"end":12},"obj":"Gene"},{"id":"590","span":{"begin":21,"end":32},"obj":"Disease"},{"id":"591","span":{"begin":82,"end":90},"obj":"Disease"},{"id":"592","span":{"begin":91,"end":101},"obj":"Disease"},{"id":"593","span":{"begin":106,"end":112},"obj":"Disease"},{"id":"600","span":{"begin":182,"end":185},"obj":"Gene"},{"id":"601","span":{"begin":673,"end":676},"obj":"Gene"},{"id":"602","span":{"begin":203,"end":214},"obj":"Disease"},{"id":"603","span":{"begin":253,"end":261},"obj":"Disease"},{"id":"604","span":{"begin":262,"end":268},"obj":"Disease"},{"id":"605","span":{"begin":276,"end":284},"obj":"Disease"}],"attributes":[{"id":"A589","pred":"tao:has_database_id","subj":"589","obj":"Gene:3046"},{"id":"A590","pred":"tao:has_database_id","subj":"590","obj":"MESH:D013789"},{"id":"A591","pred":"tao:has_database_id","subj":"591","obj":"MESH:C000657245"},{"id":"A592","pred":"tao:has_database_id","subj":"592","obj":"MESH:D007239"},{"id":"A593","pred":"tao:has_database_id","subj":"593","obj":"MESH:D003643"},{"id":"A600","pred":"tao:has_database_id","subj":"600","obj":"Gene:3046"},{"id":"A601","pred":"tao:has_database_id","subj":"601","obj":"Gene:6717"},{"id":"A602","pred":"tao:has_database_id","subj":"602","obj":"MESH:D013789"},{"id":"A603","pred":"tao:has_database_id","subj":"603","obj":"MESH:C000657245"},{"id":"A604","pred":"tao:has_database_id","subj":"604","obj":"MESH:D003643"},{"id":"A605","pred":"tao:has_database_id","subj":"605","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Table 1 HbE and any Thalassemia carrier prevalence are given and opposed against COVID-19 infections and deaths per one million (M) population [1,3,4,13,15–32].\nPrevalence/Country HbE carrier (%) Any thalassemia carrier (%) HERD immunity limit (%) COVID-19 deaths per M COVID-19 cases per M\nThailand 53 52.6 43 0.86 55.76\nLaos 53 52.6 43 0 3.3\nCambodia 62 62.7 43 0 18.18\nMyanmar 42 44.1 43 30.8 1376.26\nIndonesia 33 56 43 57.03 1757.74\nYunnan Province (China) 39.1 21.7 43 0.43 4.09\nVietnam 35.6 30 43 0.36 13.4\nIndia 30 21 43 95.77 6524.88\nBangladesh 8.68 11.89 43 38.28 2678.73\nMalaysia 3.8 16.25 43 10.07 1596.74\nSri Lanka 0.5 15.8 43 3.41 879.88\nHong Kong 2 10 43 1.84 269.44\nPhilippines 2 8.2 43 72.99 3772.82\nPakistan 0.4 9 43 34.23 1668.98\nTaiwan 0.027 8.4 43 0.29 25.57\nSingapore 0.64 3.85 43 4.79 9937.71\nBrazil 1.81 43 790.65 28785.87\nSpain 0.92 43 933.98 34110.80\nFrance 3.2 43 769.64 32996.77\nItaly 12 43 848.57 24065.13\nGreece 15 43 129.23 9127.55\nCyprus 35 43 52.52 10502.35"}

{"project":"LitCovid-sentences","denotations":[{"id":"T111","span":{"begin":0,"end":161},"obj":"Sentence"},{"id":"T112","span":{"begin":162,"end":296},"obj":"Sentence"},{"id":"T113","span":{"begin":297,"end":332},"obj":"Sentence"},{"id":"T114","span":{"begin":333,"end":359},"obj":"Sentence"},{"id":"T115","span":{"begin":360,"end":392},"obj":"Sentence"},{"id":"T116","span":{"begin":393,"end":429},"obj":"Sentence"},{"id":"T117","span":{"begin":430,"end":467},"obj":"Sentence"},{"id":"T118","span":{"begin":468,"end":519},"obj":"Sentence"},{"id":"T119","span":{"begin":520,"end":553},"obj":"Sentence"},{"id":"T120","span":{"begin":554,"end":587},"obj":"Sentence"},{"id":"T121","span":{"begin":588,"end":631},"obj":"Sentence"},{"id":"T122","span":{"begin":632,"end":672},"obj":"Sentence"},{"id":"T123","span":{"begin":673,"end":711},"obj":"Sentence"},{"id":"T124","span":{"begin":712,"end":746},"obj":"Sentence"},{"id":"T125","span":{"begin":747,"end":786},"obj":"Sentence"},{"id":"T126","span":{"begin":787,"end":823},"obj":"Sentence"},{"id":"T127","span":{"begin":824,"end":859},"obj":"Sentence"},{"id":"T128","span":{"begin":860,"end":900},"obj":"Sentence"},{"id":"T129","span":{"begin":901,"end":936},"obj":"Sentence"},{"id":"T130","span":{"begin":937,"end":971},"obj":"Sentence"},{"id":"T131","span":{"begin":972,"end":1006},"obj":"Sentence"},{"id":"T132","span":{"begin":1007,"end":1039},"obj":"Sentence"},{"id":"T133","span":{"begin":1040,"end":1072},"obj":"Sentence"},{"id":"T134","span":{"begin":1073,"end":1105},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Table 1 HbE and any Thalassemia carrier prevalence are given and opposed against COVID-19 infections and deaths per one million (M) population [1,3,4,13,15–32].\nPrevalence/Country HbE carrier (%) Any thalassemia carrier (%) HERD immunity limit (%) COVID-19 deaths per M COVID-19 cases per M\nThailand 53 52.6 43 0.86 55.76\nLaos 53 52.6 43 0 3.3\nCambodia 62 62.7 43 0 18.18\nMyanmar 42 44.1 43 30.8 1376.26\nIndonesia 33 56 43 57.03 1757.74\nYunnan Province (China) 39.1 21.7 43 0.43 4.09\nVietnam 35.6 30 43 0.36 13.4\nIndia 30 21 43 95.77 6524.88\nBangladesh 8.68 11.89 43 38.28 2678.73\nMalaysia 3.8 16.25 43 10.07 1596.74\nSri Lanka 0.5 15.8 43 3.41 879.88\nHong Kong 2 10 43 1.84 269.44\nPhilippines 2 8.2 43 72.99 3772.82\nPakistan 0.4 9 43 34.23 1668.98\nTaiwan 0.027 8.4 43 0.29 25.57\nSingapore 0.64 3.85 43 4.79 9937.71\nBrazil 1.81 43 790.65 28785.87\nSpain 0.92 43 933.98 34110.80\nFrance 3.2 43 769.64 32996.77\nItaly 12 43 848.57 24065.13\nGreece 15 43 129.23 9127.55\nCyprus 35 43 52.52 10502.35"}